CannTrust Holdings Inc. Stock Other OTC
Equities
CNTTQ
CA1378002077
Pharmaceuticals
Financials (USD)
Sales 2017 | 20.7 | Sales 2018 | 45.65 | Capitalization | 508M |
---|---|---|---|---|---|
Net income 2017 | 6M | Net income 2018 | -13M | EV / Sales 2017 | 31,215,427 x |
Net cash position 2017 | 17.16M | Net cash position 2018 | 58M | EV / Sales 2018 | 9,864,003 x |
P/E ratio 2017 |
81.5
x | P/E ratio 2018 |
-34.5
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-18 |
David Blair
DFI | Director of Finance/CFO | - | 19-09-30 |
Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-18 |
Dan Hogan
BRD | Director/Board Member | - | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+37.12% | 6.02B | |
-14.61% | 4.55B | |
-10.58% | 3.13B | |
+0.86% | 3.07B | |
-0.94% | 2.57B | |
+36.18% | 1.82B | |
-10.82% | 1.63B | |
-4.89% | 1.57B | |
-12.50% | 1.54B |